Next Article in Journal
Spectral Engineering of Hybrid Biotemplated Photonic/Photocatalytic Nanoarchitectures
Next Article in Special Issue
Formulation, Optimization and Evaluation of Cytarabine-Loaded Iron Oxide Nanoparticles: From In Vitro to In Vivo Evaluation of Anticancer Activity
Previous Article in Journal
Graphene Nanoflake- and Carbon Nanotube-Supported Iron–Potassium 3D-Catalysts for Hydrocarbon Synthesis from Syngas
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nanomaterials
Volume 12
Issue 24
10.3390/nano12244494
nanomaterials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Nanoparticles in Drug Delivery: From History to Therapeutic Applications

by
Obaid Afzal
1,
Abdulmalik S. A. Altamimi
1,
Muhammad Shahid Nadeem
2,*,
Sami I. Alzarea
3,
Waleed Hassan Almalki
4,
Aqsa Tariq
5,
Bismillah Mubeen
5,
Bibi Nazia Murtaza
6,
Saima Iftikhar
7,
Naeem Riaz
8 and
Imran Kazmi
2,*
1
Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia
2
Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3
Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia
4
Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia
5
Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore 54000, Pakistan
6
Department of Zoology, Abbottabad University of Science and Technology (AUST), Abbottabad 22310, Pakistan
7
School of Biological Sciences, University of Punjab, Lahore 54000, Pakistan
8
Department of Pharmacy, COMSATS University, Abbottabad 22020, Pakistan
*
Authors to whom correspondence should be addressed.
Nanomaterials 2022, 12(24), 4494; https://doi.org/10.3390/nano12244494
Submission received: 11 November 2022 / Revised: 4 December 2022 / Accepted: 14 December 2022 / Published: 19 December 2022
(This article belongs to the Special Issue Nanoparticles: Properties and Potential Applications in Tumor Diagnosis and Therapy)
Browse Figures
Versions Notes

Abstract

Current research into the role of engineered nanoparticles in drug delivery systems (DDSs) for medical purposes has developed numerous fascinating nanocarriers. This paper reviews the various conventionally used and current used carriage system to deliver drugs. Due to numerous drawbacks of conventional DDSs, nanocarriers have gained immense interest. Nanocarriers like polymeric nanoparticles, mesoporous nanoparticles, nanomaterials, carbon nanotubes, dendrimers, liposomes, metallic nanoparticles, nanomedicine, and engineered nanomaterials are used as carriage systems for targeted delivery at specific sites of affected areas in the body. Nanomedicine has rapidly grown to treat certain diseases like brain cancer, lung cancer, breast cancer, cardiovascular diseases, and many others. These nanomedicines can improve drug bioavailability and drug absorption time, reduce release time, eliminate drug aggregation, and enhance drug solubility in the blood. Nanomedicine has introduced a new era for drug carriage by refining the therapeutic directories of the energetic pharmaceutical elements engineered within nanoparticles. In this context, the vital information on engineered nanoparticles was reviewed and conferred towards the role in drug carriage systems to treat many ailments. All these nanocarriers were tested in vitro and in vivo. In the coming years, nanomedicines can improve human health more effectively by adding more advanced techniques into the drug delivery system.
Keywords: drug delivery; nanomedicine; therapeutics; nanoparticles; personalized medicine drug delivery; nanomedicine; therapeutics; nanoparticles; personalized medicine

Share and Cite

MDPI and ACS Style

Afzal, O.; Altamimi, A.S.A.; Nadeem, M.S.; Alzarea, S.I.; Almalki, W.H.; Tariq, A.; Mubeen, B.; Murtaza, B.N.; Iftikhar, S.; Riaz, N.; et al. Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials 2022, 12, 4494. https://doi.org/10.3390/nano12244494

AMA Style

Afzal O, Altamimi ASA, Nadeem MS, Alzarea SI, Almalki WH, Tariq A, Mubeen B, Murtaza BN, Iftikhar S, Riaz N, et al. Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials. 2022; 12(24):4494. https://doi.org/10.3390/nano12244494

Chicago/Turabian Style

Afzal, Obaid, Abdulmalik S. A. Altamimi, Muhammad Shahid Nadeem, Sami I. Alzarea, Waleed Hassan Almalki, Aqsa Tariq, Bismillah Mubeen, Bibi Nazia Murtaza, Saima Iftikhar, Naeem Riaz, and et al. 2022. "Nanoparticles in Drug Delivery: From History to Therapeutic Applications" Nanomaterials 12, no. 24: 4494. https://doi.org/10.3390/nano12244494

APA Style

Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., & Kazmi, I. (2022). Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials, 12(24), 4494. https://doi.org/10.3390/nano12244494

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop